Inolitazone is a high-affinity PPARγ agonist for anaplastic thyroid carcinoma research
**Background** Anaplastic thyroid carcinoma (ATC) is one of the most aggressive forms of thyroid cancer, characterized by rapid growth, early metastasis, and a very poor clinical prognosis. Due to its…